Schroder Investment Management Group Corcept Therapeutics Inc Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$19.95 - $29.96 $240,118 - $360,598	-12,036 Reduced 11.05%	96,914 $1.97 Million
Q3 2022 Nov 10, 2022	SELL	$24.7 - $29.12 $1.3 Million - $1.53 Million	-52,572 Reduced 32.55%	108,950 $2.79 Million
Q2 2022 Aug 11, 2022	BUY	$17.33 - $25.3 $530,090 - $773,876	30,588 Added 23.36%	161,522 $4 Million
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $125,380 - $191,217	-7,585 Reduced 5.48%	130,934 $3.17 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $85,329 - $116,466	-4,990 Reduced 3.48%	138,519 $2.74 Million
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $236,317 - $270,540	-12,008 Reduced 7.72%	143,509 $2.82 Million
Q2 2021 Aug 13, 2021	BUY	$19.97 - $24.43 $703,283 - $860,351	35,217 Added 29.27%	155,517 $3.42 Million
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $3.28 Million - $4.27 Million	-139,622 Reduced 53.72%	120,300 $2.86 Million
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $1.55 Million - $2.52 Million	92,176 Added 54.95%	259,922 $6.8 Million
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $113,797 - $182,477	-9,133 Reduced 5.16%	167,746 $2.84 Million
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $311,828 - $517,634	-28,348 Reduced 13.81%	176,879 $2.98 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $1.89 Million - $2.63 Million	187,365 Added 1048.96%	205,227 $2.37 Million
Q4 2019 Feb 11, 2020	BUY	$12.06 - $16.96 $16,992 - $23,896	1,409 Added 8.56%	17,862 $216,000
Q3 2019 Nov 12, 2019	BUY	$10.41 - $14.66 $171,275 - $241,200	16,453 New	16,453 $240,000
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $364,173 - $464,492	-29,680 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$15.3 - $19.69 $8,063 - $10,376	527 Added 1.81%	29,680 $469,000
Q1 2018 May 11, 2018	BUY	$14.59 - $25.5 $24,292 - $42,457	1,665 Added 6.06%	29,153 $480,000
Q4 2017 Feb 09, 2018	BUY	$15.77 - $20.72 $73,929 - $97,135	4,688 Added 20.56%	27,488 $496,000
Q3 2017 Nov 09, 2017	BUY	$12.3 - $19.3 $280,440 - $440,040	22,800	22,800 $432,000

Others Institutions Holding CORT

# of Institutions

355

Shares Held

86.2M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$1.11 Billion
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$670 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.1M
Shares

$542 Million
16.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$436 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$255 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account